CONCLUSIONS: SVD and NSVD failures had distinct valve types and reintervention timing, with SVD having a longer time to TAVR reintervention, but the failure mechanism did not impact reintervention type or clinical outcomes.
Read more...CONCLUSIONS: Among patients with moderate or severe post-thrombotic syndrome and iliac-vein obstruction, endovascular therapy led to less severe post-thrombotic syndrome and better health-related quality of life than standard care over a 6-month period but with a higher risk of bleeding.[…]
Read more...CONCLUSIONS AND RELEVANCE: Early US real-world experience with TTVR confirms safety and effectiveness in patients with severe TR. Thirty-day outcomes are consistent with the TRISCEND II pivotal trial, demonstrating acceptable safety, near-complete TR elimination, and significant health status improvements in[…]
Read more...CONCLUSIONS: In CS, net wave intensity was more negative, and wave speed increased. MCS was associated with changes in forward and reflected wave characteristics, consistent with altered RV-pulmonary arterial coupling. WIA parameters were associated with structural and functional cardiac measures[…]
Read more...CONCLUSION: CS patients receiving HRT exhibited less SCAI stage E and phenotype III, more favorable COMRI-CS profiles, and lower mortality despite higher complication rates. Robust risk predictors for post-HRT outcomes in CS are needed.
Read more...CONCLUSIONS: Women had a similar referral rate for AVR (versus men), with a lower proportion undergoing SAVR, allowing similar outcomes between women and men with moderate and severe AS. The lower mortality rate in women was restricted to mild AS[…]
Read more...CONCLUSIONS: Patients meeting the landmark CS trial criteria represent a small, high-risk subset of the real-world CS population, highlighting a substantial evidence gap for the majority of CS patients receiving tMCS in clinical practice. Enhancing registry enrollment of specific CS[…]
Read more...CONCLUSIONS: Approximately one-fifth of treatment for intermediate coronary stenoses was discordant with μQFR assessment. μQFR-concordant treatment was associated with lower TVF, primarily due to fewer ID-TVR. Integrating μQFR into clinical decision-making may help optimize revascularization strategies and improve outcomes in[…]
Read more...Cardiogenic shock (CS) is a complex and heterogeneous clinical syndrome associated with high short-term mortality as well as a long-term burden of morbidity. Whereas short-term survival has improved owing to early recognition, revascularization, and temporary mechanical circulatory support (tMCS), survival[…]
Read more...Read more...
1700 Broadway, 9th Floor
New York, NY 10019
646.434.4500
Please e-mail us if you would
like more information:
info@crf.org
© 2026, Cardiovascular Research Foundation®. All rights reserved.
